drugset / Trial / NCT00467662

Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)

NCT00467662

Phase 4 Unknown 75 enrolled Hadassah Medical Organization
RandomizedFactorialDouble-blindTreatment

Summary

Recurrent cold sores - herpes simplex labialis (HSL) occurs in 20-40% of the US population and patient seek treatment because of the discomfort and visibility of the lesion although it is a self limiting disease. The purpose of this study is to check the safety, Efficacy and convenience of Use of the Natural Agent "Superlysin Gel" as Treatment for Herpes Labialis in Comparison to Acyclovir 5% and Docozanole 10%.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyclovir Small molecule 5 % Topical
Subject Docosanol Small molecule 10 % Topical

Indications